Publications by authors named "Kelly Matheson"
Article Synopsis
- Patients with schizophrenia experience high rates of metabolic issues, leading to a significant loss of life due to cardiovascular diseases, prompting research into potential treatments.
- In a study of 30 overweight or obese individuals under 40 with schizophrenia and prediabetes/type 2 diabetes, participants were given either metformin or a placebo for 4 months to assess glucose and insulin improvements.
- Results showed that metformin significantly lowered insulin resistance and fasting blood glucose compared to placebo, indicating its effectiveness in managing dysglycemia and insulin sensitivity in this high-risk population, despite no major differences in other health measures.
Purpose: Effects on energy metabolism of a test meal and a two-week dietary intervention were observed in men with metabolic syndrome (MetS). Both the meal and the intervention included foods containing fish-derived n-3 polyunsaturated fats (PUFA).
Methods: Six men with MetS (46.